GlassScriptPhysician profile
Ryan Brett Krochak
NPI 1982993762
$11,185.80
in general payments reported to CMS, 2019-2025
13 companies · $3,517 in 2025
The $3,517 reported for 2025 was more than what 77% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $28.33 · 2021: $605 · 2022: $1,746 · 2023: $317 · 2024: $4,813 · 2025: $3,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,475 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,115 · Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,475.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,115.00 |
| Food and Beverage | $1,057.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $7,624.97 | 2024-2025 | Maci |
| Gotham Surgical Solutions & Devices, INC. | $1,640.62 | 2021-2022 | |
| Arcuro Medical INC | $382.36 | 2024-2025 | Superball, Superball |
| Depuy Synthes Sales INC. | $315.09 | 2022-2023 | Vapr |
| Horizon Therapeutics Plc | $301.00 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $280.34 | 2021-2022 | |
| Stryker Corporation | $161.34 | 2025 | Alphavent |
| Bioventus LLC | $143.81 | 2023 | Agili-C |
| Linvatec Corporation | $105.36 | 2024 | Allograft Tissue, Biobrace 23mm |
| Djo, LLC | $103.81 | 2021 | |
| Polaris Technology Solutions LLC | $55.74 | 2025 | |
| Arteriocyte Medical Systems, INC. | $39.95 | 2021 | |
| Ferring Pharmaceuticals INC. | $31.41 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Krochak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.